IBDEI10N ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16337,1,4,0)
 ;;=4^N52.39
 ;;^UTILITY(U,$J,358.3,16337,2)
 ;;=^5015761
 ;;^UTILITY(U,$J,358.3,16338,0)
 ;;=N52.33^^88^876^42
 ;;^UTILITY(U,$J,358.3,16338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16338,1,3,0)
 ;;=3^Erectile Dysfunction Following Urethral Surgery
 ;;^UTILITY(U,$J,358.3,16338,1,4,0)
 ;;=4^N52.33
 ;;^UTILITY(U,$J,358.3,16338,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,16339,0)
 ;;=N52.32^^88^876^39
 ;;^UTILITY(U,$J,358.3,16339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16339,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,16339,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,16339,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,16340,0)
 ;;=N52.31^^88^876^40
 ;;^UTILITY(U,$J,358.3,16340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16340,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,16340,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,16340,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,16341,0)
 ;;=N52.2^^88^876^46
 ;;^UTILITY(U,$J,358.3,16341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16341,1,3,0)
 ;;=3^Erectile Dysfunction,Drug-Induced
 ;;^UTILITY(U,$J,358.3,16341,1,4,0)
 ;;=4^N52.2
 ;;^UTILITY(U,$J,358.3,16341,2)
 ;;=^5015756
 ;;^UTILITY(U,$J,358.3,16342,0)
 ;;=N52.03^^88^876^37
 ;;^UTILITY(U,$J,358.3,16342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16342,1,3,0)
 ;;=3^Erectile Dysfunction Comb Artrl Insuff & Corporo-Venous Occlusv
 ;;^UTILITY(U,$J,358.3,16342,1,4,0)
 ;;=4^N52.03
 ;;^UTILITY(U,$J,358.3,16342,2)
 ;;=^5015754
 ;;^UTILITY(U,$J,358.3,16343,0)
 ;;=N52.02^^88^876^38
 ;;^UTILITY(U,$J,358.3,16343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16343,1,3,0)
 ;;=3^Erectile Dysfunction Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,16343,1,4,0)
 ;;=4^N52.02
 ;;^UTILITY(U,$J,358.3,16343,2)
 ;;=^5015753
 ;;^UTILITY(U,$J,358.3,16344,0)
 ;;=N52.1^^88^876^45
 ;;^UTILITY(U,$J,358.3,16344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16344,1,3,0)
 ;;=3^Erectile Dysfunction d/t Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,16344,1,4,0)
 ;;=4^N52.1
 ;;^UTILITY(U,$J,358.3,16344,2)
 ;;=^5015755
 ;;^UTILITY(U,$J,358.3,16345,0)
 ;;=N52.01^^88^876^44
 ;;^UTILITY(U,$J,358.3,16345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16345,1,3,0)
 ;;=3^Erectile Dysfunction d/t Arterial Insufficiency
 ;;^UTILITY(U,$J,358.3,16345,1,4,0)
 ;;=4^N52.01
 ;;^UTILITY(U,$J,358.3,16345,2)
 ;;=^5015752
 ;;^UTILITY(U,$J,358.3,16346,0)
 ;;=N95.2^^88^876^88
 ;;^UTILITY(U,$J,358.3,16346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16346,1,3,0)
 ;;=3^Postmenopausal Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,16346,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,16346,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,16347,0)
 ;;=R30.9^^88^876^69
 ;;^UTILITY(U,$J,358.3,16347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16347,1,3,0)
 ;;=3^Micturition Painful,Unspec
 ;;^UTILITY(U,$J,358.3,16347,1,4,0)
 ;;=4^R30.9
 ;;^UTILITY(U,$J,358.3,16347,2)
 ;;=^5019324
 ;;^UTILITY(U,$J,358.3,16348,0)
 ;;=R30.0^^88^876^28
 ;;^UTILITY(U,$J,358.3,16348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16348,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,16348,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,16348,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,16349,0)
 ;;=R33.9^^88^876^119
 ;;^UTILITY(U,$J,358.3,16349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16349,1,3,0)
 ;;=3^Urine Retention,Unspec
